Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia
Clinical trial NCT06572449 · COMPLETED
Trial details
- NCT number
- NCT06572449
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-28
- Primary completion
- 2025-03-13
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.